HIGHLIGHTS
- who: Jason Thomas Duskey et al. from the TeFarT.I., Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy have published the research work: Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments, in the Journal: Pharmaceutics 2022, 14, 1450. of /2022/
- what: A rapidly increasing number of studies are being published searching for novel ligands to be incorporated onto the surface of NMeds to achieve specific delivery to organs , cells , or even intracellular locations , with several studies focusing on permeating the blood-brain barrier (BBB) for brain targeting . The third strategy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.